| Ajanta Pharma Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532331 |
NSE Symbol : AJANTPHARM |
P/E(TTM) : 48.15 |
|
ISIN Demat : INE031B01049 |
Div & Yield% : 1.61 |
EPS(TTM) : 66.55 |
|
Book Value(₹) : 273.25 |
Market Cap(₹Cr) : 40,029.33 |
Face Value(₹) : 2.00 |
| Particulars | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Gross Sales | 1,077.27 | 926.07 | 1,085.29 | 945.18 | 1,014.58 | 848.86 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 1,077.27 | 926.07 | 1,085.29 | 945.18 | 1,014.58 | 848.86 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 28.37 | 33.68 | 13.73 | 52.16 | 31.46 | 36.75 |
| Total Income | 1,105.64 | 959.75 | 1,099.02 | 997.34 | 1,046.04 | 885.61 |
| Total Expenditure | 761.44 | 698.92 | 758.11 | 671.53 | 737.68 | 704.33 |
| PBIDT | 344.20 | 260.83 | 340.91 | 325.81 | 308.36 | 181.28 |
| Interest | 0.72 | 1.42 | 2.36 | 2.27 | 0.75 | 1.21 |
| PBDT | 343.48 | 259.41 | 338.55 | 323.54 | 307.61 | 180.07 |
| Depreciation | 32.92 | 33.47 | 33.41 | 33.04 | 32.24 | 32.11 |
| Tax | 71.42 | 59.83 | 81.94 | 75.23 | 60.58 | 39.20 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 3.11 | 3.42 | 3.05 | 2.91 | 2.75 | -8.45 |
| Reported Profit After Tax | 236.03 | 162.69 | 220.15 | 212.36 | 212.04 | 117.21 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 236.03 | 162.69 | 220.15 | 212.36 | 212.04 | 117.21 |
| EPS (Unit Curr.) | 18.77 | 12.92 | 17.48 | 16.87 | 16.84 | 9.15 |
| EPS (Adj) (Unit Curr.) | 18.77 | 12.92 | 17.48 | 16.87 | 16.84 | 9.15 |
| Calculated EPS (Unit Curr.) | 18.83 | 12.88 | 17.42 | 16.81 | 16.78 | 9.28 |
| Calculated EPS (Adj) (Unit Curr.) | 18.83 | 12.88 | 17.42 | 16.81 | 16.78 | 9.28 |
| Calculated EPS (Ann.) (Unit Curr.) | 75.32 | 51.50 | 69.70 | 67.23 | 67.13 | 37.11 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 75.32 | 51.50 | 69.70 | 67.23 | 67.13 | 37.11 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 1,300.00 | 0.00 | 1,250.00 | 0.00 |
| Equity | 25.07 | 25.27 | 25.27 | 25.27 | 25.27 | 25.27 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 31.95 | 28.17 | 31.41 | 34.47 | 30.39 | 21.36 |
| PBDTM(%) | 31.88 | 28.01 | 31.19 | 34.23 | 30.32 | 21.21 |
| PATM(%) | 21.91 | 17.57 | 20.28 | 22.47 | 20.90 | 13.81 |